Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2017 08:30 ET | Source: Aptose Biosciences Inc.

Aptose Biosciences to Present at Canaccord Genuity 37th Annual Growth Conference

SAN DIEGO and TORONTO, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the...
August 01, 2017 08:30 ET | Source: Aptose Biosciences Inc.

Aptose To Release Second Quarter Ended June 30, 2017 Financial Results and Hold Conference Call on August 8, 2017

SAN DIEGO and TORONTO, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target...
June 06, 2017 16:05 ET | Source: Aptose Biosciences Inc.

Aptose Biosciences Announces Results of Annual Meeting of Shareholders

SAN DIEGO and TORONTO, June 06, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated...
May 11, 2017 16:02 ET | Source: Aptose Biosciences Inc.

Aptose Reports Results for the First Quarter Ended March 31, 2017

SAN DIEGO and TORONTO, May 11, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated...
May 08, 2017 08:00 ET | Source: Aptose Biosciences Inc.

OHSU and Aptose Present CG’806 Preclinical Data Demonstrating Potent Activity Against Patient Samples at AACR Hematologic Malignancies Meeting

PORTLAND, Ore., SAN DIEGO, and TORONTO, May 08, 2017 (GLOBE NEWSWIRE) -- Oregon Health & Science University (OHSU) and Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) announced the...
May 08, 2017 08:00 ET | Source: Aptose Biosciences Inc.

Preclinical Data on Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented at AACR Hematologic Malignancies Meeting

SAN DIEGO and TORONTO, May 08, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) today announced the presentation of preclinical data demonstrating that CG’806, a highly...
April 25, 2017 08:30 ET | Source: Aptose Biosciences Inc.

Aptose Biosciences to Participate at the Bloom Burton & Co. Healthcare Investor Conference 2017

SAN DIEGO and TORONTO, April 25, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO), (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the...
April 24, 2017 08:30 ET | Source: Aptose Biosciences Inc.

Aptose To Release First Quarter Ended March 31, 2017 Financial Results and Hold Conference Call on May 11, 2017

SAN DIEGO and TORONTO, April 24, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target...
April 19, 2017 08:30 ET | Source: Aptose Biosciences Inc.

Aptose Biosciences to Present CG’806 Data at AACR Hematologic Malignancies Meeting

SAN DIEGO and TORONTO, April 19, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the...
March 28, 2017 17:03 ET | Source: Aptose Biosciences Inc.

Aptose Reports Fourth Quarter and Year End 2016 Results

SAN DIEGO and TORONTO, March 28, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the...